dosedrugsOnlineOfflineع
You're offline — running on data saved to your device.

Pazopanib: prices and alternatives

Pazopanib is a multi-targeted tyrosine kinase inhibitor indicated for adults with advanced renal cell carcinoma (RCC) and advanced soft tissue sarcoma (STS) who have previously received chemotherapy. It is not effective for adipocytic soft tissue sarcoma or gastrointestinal stromal tumors.

2 products with this active ingredient from 1 manufacturer. Official prices from 4641 to 9281 EGP.

Every box with this active ingredient, cheapest first.

Votrient 200 mg 30 f.c. tabVotrient 200 mg 30 f.c. tabفوترينت 200مجم 30 اقراصpazopanib · Glaxo Smithkline / Novartis Scientific OfficeOfficial public price4641EGP
Votrient 400mg 30 f.c. tabVotrient 400mg 30 f.c. tabفوترينت 400مجم 30 قرصpazopanib · Glaxo Smithkline / Novartis Scientific OfficeOfficial public price9281EGP

Informational only — may be inaccurate or incomplete. Don't rely on it medically; verify with a pharmacist.